by Dr. Geoffrey Sher | Jan 25, 2017 | Ovarian Stimulation, Ovarian Stimulation Protocols
Conventional GnRH Antagonist (GnRHa) Protocols GnRH antagonists (e.g. Ganirelix, Cetrotide, and Orgalutron) are currently used with many controlled ovarian stimulation (COS) protocols. The conventional approach is to administer 250mcg antagonist, daily starting from...
by Dr. Geoffrey Sher | Jan 20, 2017 | Uncategorized
Unless tests for immunologic implantation dysfunction (IID) immunologic implantation dysfunction are performed correctly and conducted by a one of the few reliable reproductive immunology reference laboratory in the United States, treatment will likely be...
by Dr. Geoffrey Sher | Jan 18, 2017 | Infertility
What is Ureaplasma? Ureaplasma urealyticum is a bacterium that belongs to the mycoplasma family. It can be detected in the reproductive tract of as many as 40% of individuals (male and female). Oftentimes, the correlation between Ureaplasma and Infertility can’t...
by Dr. Geoffrey Sher | Jan 10, 2017 | Uncategorized
All multiple pregnancies pose a risk to both mother and offspring. Pregnancy induced maternal complications such as miscarriage, pre-eclampsia, antepartum and post-partum hemorrhage become progressively more prevalent the higher the multiple gestation. For the babies,...
by Dr. Geoffrey Sher | Dec 22, 2016 | Uncategorized
Ovarian hyperstimulation syndrome (OHSS) is a life-endangering condition that occurs following ovarian stimulation for the treatment of infertility. It occurs due to overstimulation of the ovaries with the development of numerous follicles in susceptible women....
